Localized RNAi Therapeutics of Chemoresistant Grade IV Glioma Using Hyaluronan-Grafted Lipid-Based Nanoparticles

Cohen, Zvi R., Ramishetti, Srinivas, Peshes-Yaloz, Naama, Goldsmith, Meir, Wohl, Anton, Zibly, Zion, Peer, Dan·2015·ACS Nano

Cited by (182)

Items 101–182 of 182

  1. DNA nanoflower Oligo-PROTAC for targeted degradation of FUS to treat neurodegenerative diseases
    Ruixin Ge, Miao Chen, Sijin Wu, Sirui Huang, Ping Zhou, Minghui Cao, Fan Zhang, Jinzhi Zang, Yigao Zhu, Jingrui Li et al. · 2025 · Nature Communications
  2. Recent advances in unraveling the molecular mechanisms and functions of HOXA11‑AS in human cancers and other diseases (Review)
    Cheng Wei, Liangjuan Zhao, Hao Liang, Yingwei Zhen, Lei Han · 2020 · Oncology Reports
  3. Optimizing Peptide-Conjugated Lipid Nanoparticles for Efficient siRNA Delivery across the Blood–Brain Barrier and Treatment of Glioblastoma Multiforme
    Haiyang Tong, Zesen Ma, Jin Yu, Dongsheng Li, Qingjun Zhu, Huajian Shi, Yun Wu, Hongyi Yang, Yanmin Zheng, Demeng Sun et al. · 2025 · ACS Chemical Biology
  4. Inhibition of glioma growth by a GOLPH3 siRNA-loaded cationic liposomes
    Zixuan Yuan, Liang Zhao, Yafei Zhang, Shun Li, Bomin Pan, Lei Hua, Zhen Wang, Chengkun Ye, Jun Lan Lu, Rutong Yu et al. · 2018 · Journal of Neuro-Oncology
  5. Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?
    Claire Gazaille, Marion Sicot, Patrick Saulnier, Joël Eyer, Guillaume Bastiat · 2021 · Frontiers in Medical Technology
  6. Ionic Driven Embedment of Hyaluronic Acid Coated Liposomes in Polyelectrolyte Multilayer Films for Local Therapeutic Delivery
    Stephen L. Hayward, David Mark Francis, Matthew J. Sis, Srivatsan Kidambi · 2015 · Scientific Reports
  7. Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines
    Inbal Hazan‐Halevy, Dalit Landesman‐Milo, Daniel Rosenblum, Shoshy Mizrahy, Brandon D. Ng, Dan Peer · 2016 · Journal of Controlled Release
  8. Nanomedicine Revisited: Next Generation Therapies for Brain Cancer
    Adip Guruprasad Bhargav, Sujan Kumar Mondal, César A. Garcia, Jordan J. Green, Alfredo Quiñones‐Hinojosa · 2020 · Advanced Therapeutics
  9. Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles
    Dorota Lubanska, Sami Alrashed, Gage T. Mason, Fatima Nadeem, Angela Awada, Mitchell DiPasquale, Alexandra Sorge, Aleena Malik, Monika Kojic, Mohamed A. R. Soliman et al. · 2022 · Scientific Reports
  10. Co-delivery of PLK1-specific shRNA and doxorubicin via core-crosslinked pH-sensitive and redox ultra-sensitive micelles for glioma therapy
    Pu Wang, Nengwei Yu, Yi Wang, Huili Sun, Zhenglin Yang, Shaobing Zhou · 2017 · Journal of Materials Chemistry B
  11. Nanotechnology in glioblastoma therapy: Advances in drug delivery systems and diagnostic approaches
    Maimoona Qindeel, Mahnoor Irfan, Sami Ullah, Sonia Fathi‐karkan, Zelal Jaber Kharaba, Abbas Rahdar, Mousa Aliahmad, M. Ali Aboudzadeh · 2024 · Journal of Drug Delivery Science and Technology
  12. Precision Medicine in Pediatric Neurooncology: A Review
    Aaron Y. Mochizuki, Isaura M. Frost, Melina B. Mastrodimos, Ashley Plant, Anthony Wang, Theodore Bruce Moore, Robert Michael Prins, Paul S. Weiss, Steven John Jonas · 2017 · ACS Chemical Neuroscience
  13. Realizing the Therapeutic Potential of Rare Earth Elements in Designing Nanoparticles to Target and Treat Glioblastoma
    Victor M. Lu, Kerrie Leanne McDonald, Helen Elizabeth Townley · 2017 · Nanomedicine
  14. Revisiting gene delivery to the brain: silencing and editing
    João Conniot, Sepehr Talebian, Susana M. N. Simões, Lino Ferreira, João Conde · 2020 · Biomaterials Science
  15. Biomimetic polysaccharide-cloaked lipidic nanovesicles/microassemblies for improving the enzymatic activity and prolonging the action time for hyperuricemia treatment
    Lan Yang, Yonghong Zhang, Jiangchuan Xie, Cailing Zhong, Dan He, Tingting Wang, Kailing Li, Yao Li, Da Shi, Ruben A Abagyan et al. · 2020 · Nanoscale
  16. Recent Advances in Lipid Nanoparticles: Nucleic Acid Therapeutics and Targeting Strategies
    Sharat Sarmah, Sourav Baidya, Mrinmoy De · 2025 · Small
  17. Lipid nanoparticle-mediated targeted mRNA delivery and its application in cancer therapy
    Yuan Sui, Xiaowen Hou, Juan Zhang, Xuechuan Hong, Hongbo Wang, Yuling Xiao, Xiaodong Zeng · 2025 · Journal of Materials Chemistry B
  18. Development of bioactive materials for glioblastoma therapy
    Jun Yang, Yan Li, Tianlu Zhang, Xin Zhang · 2016 · Bioactive Materials
  19. Synergistic Enhancement of Cellular Uptake With CD44-Expressing Malignant Pleural Mesothelioma by Combining Cationic Liposome and Hyaluronic Acid–Lipid Conjugate
    Yu Sakurai, Akari Kato, Yasuhiro Hida, Junichi Hamada, Nako Maishi, Kyoko Hida, Hideyoshi Harashima · 2019 · Journal of Pharmaceutical Sciences
  20. Molecular Determinants for Cyclo-Oligosaccharide-Based Nanoparticle-Mediated Effective siRNA Transfection
    Darío Manzanares, Ingrid Araya‐Durán, Laura Gallego‐Yerga, Pablo Játiva, Valeria Márquez‐Miranda, Jonathan Canan, José Luis Jiménez Blanco, Carmen Ortiz Mellet, Fernando Danilo González-Nilo, José Manuel García Fernández et al. · 2017 · Nanomedicine
  21. Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations
    Laura Pineiro‐Alonso, Inés Rubio-Prego, Alexandra Lobyntseva, Eva González‐Freire, Róbert Langer, Marı́a José Alonso · 2025 · Advanced Drug Delivery Reviews
  22. Biopolymeric Nanoparticles for Targeted Drug Delivery to Brain Tumors
    Ahmed O. Elzoghby, May S. Freag, Kadria A. Elkhodairy · 2018 · Elsevier eBooks
  23. Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer
    Krishan Kumar, Ruchi Chawla · 2021 · Journal of Drug Delivery Science and Technology
  24. Suppression of the Smurf1 Expression Inhibits Tumor Progression in Gliomas
    Hao Chang, Jingning Zhang, Zengli Miao, Yasuo Ding, Xing Xu, Xudong Zhao, Peng Xu, Qing Wang, Yuchang Lin · 2017 · Cellular and Molecular Neurobiology
  25. Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells
    Fernando Francisco Borges Resende, Simoneide Souza Titze-de-Almeida, Ricardo Titze‐de‐Almeida · 2018 · Oncology Letters
  26. Suppressing nNOS Enzyme by Small-Interfering RNAs Protects SH-SY5Y Cells and Nigral Dopaminergic Neurons from 6-OHDA Injury
    Titze-de-Almeida, Ricardo, Titze-de-Almeida, Simoneide S., Ferreira, Nadia Rubia, Fontanari, Caroline, Faccioli, Lúcia Helena, Del Bel, Elaine · 2019 · Neurotoxicity Research
  27. Localized treatment of glioblastoma: a review of clinical strategies and advances in drug delivery systems
    Cristiano Pesce, Giulia Rodella, Agnese Fragassi, Mariangela Garofalo, Stefano Salmaso, Paolo Caliceti, Bernard Gallez, Alessio Malfanti · 2025 · Nanomedicine
  28. Optimal delivery strategies for nanoparticle-mediated mRNA delivery
    Xiaoyan Li, Xiaocui Guo, Mingdi Hu, Rong Cai, Chunying Chen · 2023 · Journal of Materials Chemistry B
  29. Spermidine/Spermine N1-Acetyltransferase 1 (SAT1)—A Potential Gene Target for Selective Sensitization of Glioblastoma Cells Using an Ionizable Lipid Nanoparticle to Deliver siRNA
    Vinith Yathindranath, Nur A. Safa, Babu V. Sajesh, Kelly Schwinghamer, Magimairajan Vanan, Rashid Ahmed Bux, DANIEL S. SITAR, Marshall W. Pitz, Teruna J. Siahaan, Donald W. Miller · 2022 · Cancers
  30. Reprogramming neural‑tumor crosstalk: emerging therapeutic dimensions and targeting strategies
    Qianqian Liu, Zi-Kai Dong, Yongfei Wang, Weilin Jin · 2025 · Military Medical Research
  31. Survivin silencing improved the cytotoxicity of carboplatin and melphalan in Y79 and primary retinoblastoma cells
    Victor Passos Gibson, Rabeb Mouna Derbali, Huu Trong Phan, Houda Tahiri, Christine J. Allen, Pierre Hardy, Jeanne Leblond Chain · 2020 · International Journal of Pharmaceutics
  32. Versatility of LNPs across different administration routes for targeted RNA delivery
    Muhammed Boye Jallow, Kun Huang, Min Qiu · 2025 · Journal of Materials Chemistry B
  33. The battle of lipid-based nanocarriers against blood-brain barrier: a critical review
    Kawthar K. Abla, Mohammed Maher Mehanna · 2023 · Journal of drug targeting
  34. MiRNA-323-5p Promotes U373 Cell Apoptosis by Reducing IGF-1R
    Hongàn Yang, Xiang Wang, Feng Ding, Qi Pang · 2015 · Medical Science Monitor
  35. Triggered RNAi Therapy Using Metal Inorganic Nanovectors
    Eva Villar‐Álvarez, Baltazar Hiram Leal-Martínez, Adriana Cambón, Alberto Pardo, Raquel Martínez-González, Javier Fernández‐Vega, Sonia Al‐Qadi, Vı́ctor Mosquera, Alberto Bouzas‐Mosquera, Sílvia Barbosa et al. · 2019 · Molecular Pharmaceutics
  36. The application of glycosylated liposomes in targeted drug delivery
    Jing Wen, Jiangtao Xu, Min Hee Hong, Jian Li, Tie Li · 2025 · Journal of Drug Delivery Science and Technology
  37. Translational Nano-medicine Lab to Clinic
    Mohammad Nadeem Khan · 2020 · Elsevier eBooks
  38. The Effectiveness of Nanoparticles on Gene Therapy for Glioblastoma Cells Apoptosis: A Systematic Review
    Firoozeh Alavian, Sorayya Ghasemi · 2021 · Current Gene Therapy
  39. Focus on RNA interference: from nanoformulations to in vivo delivery
    Jeffrey M. Karp, Dan Peer · 2017 · Nanotechnology
  40. Potential roles of hyaluronic acid in in vivo CAR T cell reprogramming for cancer immunotherapy
    Chavee Laomeephol, Sudartip Areecheewakul, Supannikar Tawinwung, Koramit Suppipat, Preedakorn Chunhacha, Nuno Meleiro Neves, Jittima Amie Luckanagul · 2022 · Nanoscale
  41. Nanotechnology and the New Frontiers of Drug Delivery in Cerebral Gliomas
    Gerardo Caruso, Lucia Merlo, Ema Tot, Cinzia Pignataro, Maria Caffo · 2017 · Elsevier eBooks
  42. The Possible Uses and Challenges of Nanomaterials in Mast Cell Research
    Brett A. Duguay, Lei Lu, Narcy G Arizmendi, Larry D. Unsworth, Marianna Kulka · 2020 · The Journal of Immunology
  43. Pulsed Microwave‐Induced Thermoacoustic Shockwave for Precise Glioblastoma Therapy with the Skin and Skull Intact
    Wenjing Li, Shanxiang Zhang, Da Xing, Huan Qin · 2022 · Small
  44. siRNA Delivery: Current Trends and Future Perspectives
    Manu Smriti Singh, Dan Peer · 2016 · Therapeutic Delivery
  45. Hampering Brain Tumor Proliferation and Migration Using Peptide Nanofiber:si PLK1 / MMP2 Complexes
    Mariarosa Mazza, Hassan Ahmad, Marilena Hadjidemetriou, Giulia Agliardi, Omar Nathan Pathmanaban, Andrew Thomas King, Brian Bigger, Sandra Vranic, Kostas Kostarelos · 2019 · Nanomedicine
  46. Wavelength modulated SERS hot spot distribution in 1D nanostructures on metal film
    Lili Wang, Xiping Zeng, Ting Liu, Xuemei Zhang, Hua Wei, Yingzhou Huang, Anping Liu, Shuxia Wang, Weijia Wen · 2016 · Journal of Physics D Applied Physics
  47. Advances in locally administered nucleic acid therapeutics
    Jie Shen, Xusheng Duan, Ting Xie, Xinrui Zhang, Yue Cai, Junhao Pan, Xin Zhang, Xuanrong Sun · 2025 · Bioactive Materials
  48. Advances in RNA therapeutics for modulation of ‘undruggable’ targets
    Emily Martinsen, Tasmia Jinnurine, Saranya Subramani, Marie Rogne · 2024 · Progress in molecular biology and translational science
  49. Nucleic acid therapy in pediatric cancer
    Yongshu Li, Bihui Huang, Zhichao Xue, Yunhua Gao, Zhenjian Zhuo · 2022 · Pharmacological Research
  50. Modification of liposomal surface by polysaccharides: Preparation, characterization, and application for drug targeting
    Jaroslav Tuřánek, Josef Mašek, Milan Raška, M Ledvina, Ema Paulovičová, František Hubatka, Jan Kotouček · 2019 · Elsevier eBooks
  51. Natural polysaccharides in colloidal drug delivery systems for brain glioma therapy: Mechanisms and advancements
    Chun Li, Weining Ma, Haitao Shen, Zhipeng Hou, Jing Chen, Liqun Yang, Wei Yan Sun · 2025 · Colloids and Surfaces B Biointerfaces
  52. The IL13α 2R paves the way for anti-glioma nanotherapy
    Ilya V. Ulasov, Anton V. Borovjagin, Anastasia Laevskaya, Мargarita Kamynina, Peter S. Timashev, Laura Cerchia, Elena A. Rozhkova · 2021 · Genes & Diseases
  53. Recent advances in development and delivery of non-viral nucleic acid therapeutics for brain tumor therapy
    Donat Kögel, Achim Temme, Achim Michael Aigner · 2024 · Pharmacology & Therapeutics
  54. De novo hyaluronic acid-based biomaterial: a promising perspective to manage neurodegenerative diseases
    Somayeh Kakehbaraei, Morteza Arab‐Zozani, Seyran Kakebaraei · 2024 · International Journal of Polymeric Materials
  55. Optimizing the targeting of lipid nanoparticles for gene therapy
    Lei Yue, Xiulei Gao, Wei Qi, Luhong Zhang, Yuefei Wang · 2025 · Nanoscale Horizons
  56. Gut Microbial Targets in Inflammatory Bowel Disease: Current Position and Future Developments
    Naveen Sivakumar, Ashwin Krishnamoorthy, Harshita Ryali, Ramesh Pulendran Arasaradnam · 2025 · Biomedicines
  57. Magnetic resonance imaging analysis predicts nanoparticle concentration delivered to the brain parenchyma
    Michael Plaksin, Tiran Bercovici, Gabriella Toltsis, Javier Grinfeld, Boaz Shapira, Yuval Zur, Rafi de Picciotto, Eyal Zadicario, Mustaffa Siddeeq, Anton Wohl et al. · 2022 · Communications Biology
  58. Novel Phytosteryl-Ester-Based Mozafari Preparation of Liposomes and Layer-by-Layer Coating
    Zhengyang Wu, Songbai Liu · 2025 · ACS Food Science & Technology
  59. Effective approaches in conquering chemoresistance of glioblastoma: potential for nanoformulations
    Madhurima Mandal, Indranil Banerjee, Mahitosh Mandal · 2025 · Drug Delivery and Translational Research
  60. The Blood-Brain Barrier in Glioblastoma: Pathology and Therapeutic Implications
    John Kealy, Matthew Campbell · 2016 · Resistance to targeted anti-cancer therapeutics
  61. Appealing to Our Broad Audience
    Raymond E. Schaak · 2015 · ACS Nano
  62. Synergic microRNAs suppress human glioblastoma progression by modulating clinically relevant targets
    Silvia Rancati, Rui Cruz Pereira, Michele Schlich, Stefania Sgroi, Silvia Beatini, Letizia La Rosa, Lidia Giantomasi, Roberta Pelizzoli, Clarissa Braccia, Andrea Di Fonzo et al. · 2025 · Molecular Therapy — Nucleic Acids
  63. Targeting Chemotherapy Resistance in Glioblastoma Through Modulation of ABC Transporters
    Amanda Tivnan · 2016 · Resistance to targeted anti-cancer therapeutics
  64. Polymeric Nanoparticle-Mediated Photodynamic Therapy: A Synergistic Approach for Glioblastoma Treatment
    Bandar E. Al‐Dhubiab, Rashed M. Almuqbil · 2025 · Pharmaceuticals
  65. Targeting Cancer Using Nanocarriers
    Dalit Landesman‐Milo, Shahd Qassem, Dan Peer · 2016 · Advances in delivery science and technology
  66. Strategies in overcoming the challenges of cytotoxic agents using smart colloidal solid lipid nanoparticles and nanostructured lipid carriers - A review
    Radharani Panda, Ketousetuo Kuotsu · 2019 · Asian Journal of Pharmacy and Pharmacology
  67. Microfluidic Fabrication of Alendronate-Modified Lipid Nanoparticles for Bone-Targeted mRNA Delivery
    Kangling Xu, Junyu Su, Hailin Ma, Yanxia Zhu · 2026 · Pharmaceutics
  68. BBB-aware stimuli-responsive and biomimetic nanomedicines for glioblastoma
    Sana Javaid, Wenqi Song, Sajid Ali, Wei Hou, Xueqiong Su, Hao Wang, Yujun Song · 2026 · Chinese Neurosurgical Journal
  69. Polymeric Nanoparticles to Target Lung Cancer
    Ashish Garg · 2022 · Environmental chemistry for a sustainable world
  70. Multiplexed Nanomedicine for Brain Tumors: Nanosized Hercules to Tame Our Lernaean Hydra inside?
    Wojciech K. Panek, Omar F. Khan, Dou Yu, Maciej S. Lesniak · 2017 · Nanomedicine
  71. DNAzyme-assisted bioconstruction of logically activatable nanoplatforms for enhanced cancer therapy
    Feng Wang, Yi Jin, Xin Gao, Haoran Huo, Bei Wang, Biao Niu, Zihan Xia, Jinchao Zhang, Xinjian Yang · 2022 · Journal of Colloid and Interface Science
  72. Impairing Proliferation of Glioblastoma Multiforme with CD44+ Selective Conjugated Polymer Nanoparticles
    Dorota Lubanska, Sami Alrashed, Gage T. Mason, Fatima Nadeem, Mitchell DiPasquale, Angela Awada, Aleena Malik, Mohamed A. R. Soliman, Ana C. deCarvalho, Abdalla Shamisa et al. · 2021
  73. Future Outlook of Nanopharmacy: Challenges and Opportunities
    Dan Peer, Jean Cornier, Marcel H. Van de Voorde · 2016
  74. Gene Silencing in the Right Place at the Right Time
    Anna Gutkin, Dan Peer · 2018 · Molecular Therapy
  75. The Advancement in Magnetic Nanoparticles for the Diagnosis of Lung Cancer and Its Monitoring
    Ayushi Rastogi, Fanindra Pati Pandey, Pankaj Kumar Tripathi, Rajiv Manohar, Shri Singh · 2021 · Preprints.org
  76. NMA joins coalition to reduce infant mortality.
    R P Epps · 1982 · PubMed Central
  77. Impairing Proliferation of Glioblastoma Multiforme with CD44+ Selective Conjugated Polymer Nanoparticles
    Dorota Lubanska, Sami Alrashed, Gage T. Mason, Fatima Nadeem, Mitchell DiPasquale, Angela Awada, Aleena Malik, Mohamed A. R. Soliman, Ana C. deCarvalho, Abdalla Shamisa et al. · 2021
  78. QbD approach for optimization and characterization of anti-glioblastoma drug embedded lipid nanoparticles for intranasal administration
    Fakhara Sabir · 2022
  79. Tunable sericin nanocarriers for controlled drug release and glioblastoma targeting
    Ionut‐Cristian Radu, Mircea Teodorescu, Celina Maria Damian, Mădălina Ioana Necolau, Eugenia Tanasă, Cristina Elena Stavarache, Roxana Cristina Popescu, Cosmin Cătălin Mustăciosu, Ariana Hudiță, Aristidis Michael Tsatsakis et al. · 2025 · Results in Engineering
  80. Hydrogel de nanocapsules lipidiques combinées au peptide de ciblage NFL-TBS.40-63 pour la prévention de récurrences de glioblastome
    Claire Gazaille · 2020
  81. Bionanomaterials-Based siRNA/miRNA Delivery Systems: Emerging Strategies for Cancer Therapy
    Mehnath Sivaraj, Vasantharaja Raguraman · 2026 · Interdisciplinary biotechnological advances
  82. Nucleic acid therapeutics for reinvigorating p53 function in glioblastoma: concepts, limitations and recent advances
    Alexander Hagstotz, Susanne Michen, Achim Aigner, Ilker Y. Eyüpoglu, Achim Temme · 2026 · Pharmacology & Therapeutics